• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

High variation between hospitals in vena cava filter use for venous thromboembolism.

机构信息

Division ofGeneral Medicine, Departmentsof Medicine, University of California, Davis, School of Medicine, Sacramento, CA 95817, USA.

出版信息

JAMA Intern Med. 2013 Apr 8;173(7):506-12. doi: 10.1001/jamainternmed.2013.2352.

DOI:10.1001/jamainternmed.2013.2352
PMID:23552572
Abstract

BACKGROUND

The extent to which vena cava filter (VCF) use varies between hospitals in the management of acute venous thromboembolism (VTE) is not clear.

METHODS

We conducted a retrospective observational study that compared the frequency of VCF use among California hospitals from January 1, 2006, through December 31, 2010. Using administrative hospital discharge data, we followed explicit criteria to identify nontrauma patients with acute VTE, and determined the frequency of VCF placement in each of the hospitals that admitted more than 55 VTE patients. Multivariable hierarchical regression models to predict VCF use included important clinical and demographic variables as fixed effects and hospital as a random effect.

RESULTS

Among the 263 hospitals included, 130 643 acute VTE hospitalizations occurred with the placement of 19 537 VCFs (14.95%). Variation in the percentage of acute VTE hospitalizations that included VCF placement was very high, from 0% to 38.96% (interquartile range, 6.23%-18.14%), with 18.49% of the observed variation due to differences among the hospitals that provided care. Significant clinical predictors of VCF use included acute bleeding at the time of admission (odds ratio, 3.4 [95% CI, 3.2-3.6]), a major operation after admission for VTE (3.4 [3.3-3.5]), presence of metastatic cancer (1.7 [1.6-1.8]), and extreme severity of illness (2.5 [2.3-2.7] vs mild). Insertion of VCFs occurred more frequently than expected in 109 hospitals and less frequently in 59. Hospital characteristics associated with VCF use included a small number of beds (odds ratio, 0.2 [95% CI, 0.2-0.4], <100 vs >400 beds), a rural location (0.4 [0.2-0.5]), and other private vs Kaiser hospitals (1.5 [1.1-2.0]). Use of VCFs varied widely even in geographically proximate areas.

CONCLUSIONS

The frequency of VCF use in patients with acute VTE varied widely and depended on which hospital provided the care, even after adjusting for clinical and socioeconomic factors. Further research is needed to determine whether this variation is associated with local cultural differences between hospitals or with differences in the availability of interventional radiologists or specialists, or whether it reflects the absence of high-quality evidence that VCFs are effective.

摘要

相似文献

1
High variation between hospitals in vena cava filter use for venous thromboembolism.医院在使用腔静脉滤器预防静脉血栓栓塞方面存在很大差异。
JAMA Intern Med. 2013 Apr 8;173(7):506-12. doi: 10.1001/jamainternmed.2013.2352.
2
Vena cava filter use in cancer patients with acute venous thromboembolism in California.加利福尼亚州癌症合并急性静脉血栓栓塞患者腔静脉滤器的使用情况
Thromb Res. 2015 May;135(5):809-15. doi: 10.1016/j.thromres.2015.02.002. Epub 2015 Feb 7.
3
Outcomes After Vena Cava Filter Use in Noncancer Patients With Acute Venous Thromboembolism: A Population-Based Study.非癌症急性静脉血栓栓塞患者使用腔静脉滤器后的结局:一项基于人群的研究。
Circulation. 2016 May 24;133(21):2018-29. doi: 10.1161/CIRCULATIONAHA.115.020338. Epub 2016 Apr 5.
4
Vena cava filters for management of venous thromboembolism: a clinical review.腔静脉滤器在静脉血栓栓塞症治疗中的应用:临床评价。
Blood Rev. 2013 Sep;27(5):225-41. doi: 10.1016/j.blre.2013.07.001. Epub 2013 Aug 7.
5
The increasing use of vena cava filters in adult trauma victims: data from the American College of Surgeons National Trauma Data Bank.成年创伤患者腔静脉滤器使用的增加:来自美国外科医师学会国家创伤数据库的数据。
J Trauma. 2007 Oct;63(4):764-9. doi: 10.1097/01.ta.0000240444.14664.5f.
6
Hospitalization metrics associated with hospital-level variation in inferior vena cava filter utilization for patients with venous thromboembolism in the United States: Implications for quality of care.美国静脉血栓栓塞症患者下腔静脉滤器应用中与医院水平变异相关的住院指标:对护理质量的影响。
Vasc Med. 2018 Aug;23(4):365-371. doi: 10.1177/1358863X18768685. Epub 2018 May 20.
7
Factors associated with recurrent venous thromboembolism in patients with malignant disease.恶性疾病患者复发性静脉血栓栓塞的相关因素。
J Vasc Surg. 2003 May;37(5):976-83. doi: 10.1067/mva.2003.191.
8
Review of indications and practices of vena caval filters at a large university hospital.大型大学医院腔静脉滤器的适应证及应用情况综述。
Vasc Endovascular Surg. 2012 Jan;46(1):21-5. doi: 10.1177/1538574411422274. Epub 2011 Dec 8.
9
Impact of consensus statements and reimbursement on vena cava filter utilization.共识声明和报销政策对腔静脉滤器使用的影响。
J Vasc Surg. 2016 Aug;64(2):425-429. doi: 10.1016/j.jvs.2016.01.046. Epub 2016 Mar 4.
10
Vena Cava Filters and In-Hospital Case Fatality Among Patients With Pulmonary Embolism: Results From a Large Population-Based Study.下腔静脉滤器与肺栓塞患者院内病死率:一项基于大样本的研究结果。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619888022. doi: 10.1177/1076029619888022.

引用本文的文献

1
Oral Rivaroxaban Versus Warfarin After inferior Vena cava Filter Implantation: A Retrospective Cohort Study.下腔静脉滤器植入术后口服利伐沙班与华法林的比较:一项回顾性队列研究。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241256938. doi: 10.1177/10760296241256938.
2
Clinical Correlates of In-Hospital Mortality in Patients Undergoing Inferior Vena Cava Filter Placement for Acute Deep Vein Thrombosis.急性深静脉血栓形成患者接受下腔静脉滤器置入术时院内死亡的临床相关因素
J Clin Med. 2024 Apr 15;13(8):2285. doi: 10.3390/jcm13082285.
3
Outcomes of acute pulmonary embolism in hospitalized patients with cancer.
癌症住院患者急性肺栓塞的结局。
BMC Pulm Med. 2022 Jan 6;22(1):11. doi: 10.1186/s12890-021-01808-9.
4
Effect of Inferior Vena Cava Filter on Venous Thromboembolism Mortality in Japan - JROAD and JROAD-DPC Registry Analysis.下腔静脉滤器对日本静脉血栓栓塞症死亡率的影响——JROAD和JROAD-DPC注册研究分析。
Circ Rep. 2019 Jun 29;1(7):296-302. doi: 10.1253/circrep.CR-19-0042.
5
Use and Removal of Inferior Vena Cava Filters in Patients With Acute Brain Injury.急性脑损伤患者下腔静脉滤器的使用与取出
Neurohospitalist. 2020 Jul;10(3):188-192. doi: 10.1177/1941874420907531. Epub 2020 Feb 28.
6
Spanish multicenter real - life registry of retrievable vena cava filters (REFiVeC).西班牙可回收腔静脉滤器多中心真实世界注册研究(REFiVeC)。
CVIR Endovasc. 2020 May 18;3(1):26. doi: 10.1186/s42155-020-00114-5.
7
Vena Cava Filters and In-Hospital Case Fatality Among Patients With Pulmonary Embolism: Results From a Large Population-Based Study.下腔静脉滤器与肺栓塞患者院内病死率:一项基于大样本的研究结果。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619888022. doi: 10.1177/1076029619888022.
8
Trends in Perioperative Venous Thromboembolism Associated with Major Noncardiac Surgery.与非心脏大手术相关的围手术期静脉血栓栓塞的趋势
TH Open. 2017 Jul;1(2):e82-e91. doi: 10.1055/s-0037-1605360.
9
Patient and hospital characteristics predictive of inferior vena cava filter usage in venous thromboembolism patients: A study from the 2013 to 2014 Nationwide Readmissions Database.静脉血栓栓塞症患者中预测下腔静脉滤器使用情况的患者及医院特征:一项基于2013至2014年全国再入院数据库的研究
Medicine (Baltimore). 2018 Mar;97(12):e0149. doi: 10.1097/MD.0000000000010149.
10
California study of Ablation (CAABL):early utilization after index hospitalization for non-valvular atrial fibrillation.加利福尼亚消融研究(CAABL):非瓣膜性心房颤动首次住院后的早期应用情况
J Atr Fibrillation. 2017 Jun 30;10(1):1599. doi: 10.4022/jafib.1599. eCollection 2017 Jun-Jul.